Abiopharma

🔍 Sobers Sean (Executive)

Company: ThredUp Inc. (TDUP)

Report Date: 2026-09-01

Detailed Transactions and Holdings:

• Acquired 36,667 shares of Class A Common Stock (Direct)
  Date: 2026-09-01 | Code: M | equity_swap_involved: 0 | shares_owned_after: 632,476.00 | transaction_form_type: 4
• Sold 18,973 shares of Class A Common Stock at $2.5812 per share (Direct)
  Date: 2026-09-02 | Code: S | equity_swap_involved: 0 | shares_owned_after: 613,503.00 | transaction_form_type: 4 | Footnotes: F1
• Acquired 25,833 shares of Class A Common Stock (Direct)
  Date: 2026-09-01 | Code: M | equity_swap_involved: 0 | shares_owned_after: 639,336.00 | transaction_form_type: 4
• Sold 13,368 shares of Class A Common Stock at $2.5812 per share (Direct)
  Date: 2026-09-02 | Code: S | equity_swap_involved: 0 | shares_owned_after: 625,968.00 | transaction_form_type: 4 | Footnotes: F1
• Acquired 23,610 shares of Class A Common Stock (Direct)
  Date: 2026-09-01 | Code: M | equity_swap_involved: 0 | shares_owned_after: 649,578.00 | transaction_form_type: 4
• Sold 12,218 shares of Class A Common Stock at $2.5812 per share (Direct)
  Date: 2026-09-02 | Code: S | equity_swap_involved: 0 | shares_owned_after: 637,360.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 36,667 shares of Restricted Stock Units (Derivative)
  Date: 2026-09-01 | Code: M | equity_swap_involved: 0 | shares_owned_after: 427,761.00 | transaction_form_type: 4 | Footnotes: F2, F3, F3
• Sold 25,833 shares of Restricted Stock Units (Derivative)
  Date: 2026-09-01 | Code: M | equity_swap_involved: 0 | shares_owned_after: 401,928.00 | transaction_form_type: 4 | Footnotes: F2, F4, F4
• Sold 23,610 shares of Restricted Stock Units (Derivative)
  Date: 2026-09-01 | Code: M | equity_swap_involved: 0 | shares_owned_after: 378,318.00 | transaction_form_type: 4 | Footnotes: F2, F5, F5

Footnotes:

• F1: Represents the number of shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.
• F2: Each RSU represents a contingent right to receive one share of the Issuer's Class A Common Stock.
• F3: On February 26, 2024, the Reporting Person was granted 440,000 RSUs, vesting in twelve equal quarterly installments on June 1, September 1, December 1 and March 1 until fully vested, subject to the Reporting Person's continued service to the Issuer on each such date.
• F4: On January 9, 2025, the Reporting Person was granted 310,000 RSUs, vesting in twelve equal quarterly installments on June 1, September 1, December 1 and March 1 until fully vested, subject to the Reporting Person's continued service to the Issuer on each such date.
• F5: On January 28, 2026, the Reporting Person was granted 283,312 RSUs, vesting in twelve equal quarterly installments on June 1, September 1, December 1 and March 1 until fully vested, subject to the Reporting Person's continued service to the Issuer on each such date.